| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |